Verona Pharma

VRNA NASDAQ
5.86
0.00
0.00%
交易中 09:30 06/25 EDT
开盘
5.86
昨收
5.86
最高
5.86
最低
5.86
成交量
5
成交均量(3M)
4,354
52周最高
16.24
52周最低
5.52
换手率
0.00%
市值
7,676.60万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Verona Pharma VRNA股票价格,Verona Pharma股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Verona Pharma plc is a United Kingdom-based clinical-stage biopharmaceutical company. The principal activity of the Company is the development of drugs for the treatment of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma and cystic fibrosis. The Company's product candidate, RPL554, is a dual inhibitor of the enzymes phosphodiesterase 3 and 4 (PDE3 and PDE4) that acts as both a bronchodilator and an anti-inflammatory agent in a single compound. The Company is developing RPL554 in a nebulized formulation for the maintenance treatment of COPD patients and for the treatment of cystic fibrosis. It also is developing RPL554 as an add-on therapy to commonly used therapies for the treatment of acute exacerbations of COPD in the hospital setting. In addition to its nebulized formulation of RPL554, the Company is developing RPL554 in both dry powder inhaler (DPI) and metered dose inhaler (MDI) formulations for the maintenance treatment of COPD.
展开 >

最近浏览

名称
价格
涨跌幅